COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Join experts in the medical field for free CME webinars covering what we know about the coronavirus outbreak.
Dr. Paul Auwaerter answers your burning questions about the COVID-19 Delta variant. Topics: *The impact of the Delta variant on masking and social distancing guidance *Risk of hospitalization and death for unvaccinated vs. vaccinated people *New FDA authorization for monoclonal antibody therapy *How do labs test for the Delta variant?
Paul G. Auwaerter, MD, MBA, FIDSA
Past President of the Infectious Diseases Society of America (IDSA)
Professor of Medicine
Johns Hopkins University School of Medicine
Collection of Information
This website collects various types of information, such as:
Voluntarily provided information, which may include your name, address, email address, billing and /or credit card information etc. This information may be used when you purchase products and/or services from DKBmed and to deliver the services you have requested.
Information automatically collected when visiting our website, which may include cookies, third-party tracking technologies, and server logs.
Please rest assured that this site shall only collect personal information that you knowingly and willingly provide by way of surveys, completed membership forms, and emails. It is the intent of this site to use personal information only for the purpose for which it was requested and any additional uses specifically provided on this site.
DKBmed, LLC, may at a later time have occasion to collect anonymous demographic information, such as age, gender, household income, political affiliation, race, and religion. We may also gather information about the type of browser you are using, IP address, or type of operating system to assist us in providing and maintaining superior-quality service.
It is suggested and highly recommended that you review the privacy policies and statements of any website you choose to use or frequent to better understand how other websites garner, use, and share information collected.
Use of Information Collected
DKBmed, LLC, may collect and may use personal information to assist in the operation of our website and to ensure delivery of the services you need and request. At times, we may find it necessary to use personally identifiable information to keep you informed of other possible products and/or services that may be available to you from DKBmed.com. DKBmed, LLC, may also contact you with regard to completing surveys and /or research questionnaires related to your opinion of current or potential future services that may be offered.
DKBmed, LLC, does not now, but may in the future, sell, rent, or lease any of our customer lists and/or names to any third parties.
DKBmed, LLC, may find it beneficial to share specific data with our trusted partners in an effort to conduct statistical analysis, provide you with email and/or postal mail, deliver support, and/or arrange for deliveries to be made. Those third parties shall be strictly prohibited from making use of your personal information, other than to deliver the services you requested, and thus they are required, in accordance with this agreement, to maintain the strictest confidentiality with regard to all your information.
DKBmed, LLC, may deem it necessary to follow websites and/or pages that our users may frequent to learn what types of services and/or products may be the most popular with our customers or the general public.
DKBmed, LLC, may disclose your personal information, without prior notice to you, only if required to do so in accordance with applicable laws and /or in a good faith belief that such action is deemed necessary or is required to:
Remain in conformance with any decrees, laws, and/or statutes or to comply with any process that may be served upon DKBmed, LLC, and/or our website;
Maintain, safeguard, and/or preserve all the rights and /or property of DKBmed, LLC; and
Perform under demanding conditions in an emergency to safeguard the personal safety of users of DKBmed.com and /or the general public.
Children Under the Age of 13
DKBmed, LLC, does not knowingly collect personal identifiable information from children under the age or thirteen (13) years without verifiable parental consent. If it is determined that such information has been inadvertently collected on anyone under the age of thirteen (13), we shall immediately take the necessary steps to ensure that such information is deleted from our system's database. Anyone under the age of thirteen (13) must seek and obtain a parent’s or guardian’s permission to use this website.
Unsubscribe or Opt Out
Users and/or visitors to our website have the option to discontinue receiving communication from us for any reason and have the right to discontinue receiving communications by email or newsletters. To discontinue or unsubscribe to our website, please send to [email protected] an email indicating that you want to unsubscribe. If you want to unsubscribe or opt out from any third-party websites linked on DKBmed.com, you must go to that specific website to unsubscribe and/or opt out.
Links to Other Web Sites
DKBmed, LLC, shall endeavor and shall take every precaution to maintain adequate physical, procedural, and technical security with respect to our offices and information storage facilities to prevent any loss, misuse, unauthorized access, disclosure, or modification of the user's personal information under our control.
Changes to Privacy Pol icy Agreement
Acceptance of Terms
How to Contact Us:
122 W. 26th St., Suite 1100
New York. New York 10001
COVID-19: Keeping Up with a Moving Target
Enduring Internet Activity
The enduring material will be available from August 4, 2021 to August 4, 2022. Jointly provided by Postgraduate Institute for Medicine, DKBmed and the Institute for Johns Hopkins Nursing (IJHN)Estimated time to complete this activity: 15 minutesFor CME questions, please visit www.pimed.com. For CNE questions, please contact the IJHN office at [email protected]
This activity is intended for health care providers in the care of patients with COVID-19. This educational activity is supported by independent medical educational grants from Gilead Sciences, Inc., Regeneron Pharmaceuticals, Inc., and Eli Lilly and Company.
After completing this activity, the participant should be better able to:
Discuss importance of completing vaccination regimen
Describe remdesivir clinical trial data
Paul G. Auwaerter, MD, MBA, FIDSA
Past President of the Infectious Diseases Society of America (IDSA)
Professor of Medicine, Johns Hopkins University School of Medicine
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until August 4, 2022. PAs should only claim credit commensurate with the extent of their participation.
Continuing Pharmacist Education
Postgraduate Institute for Medicine designates this continuing education activity for .25 contact hour(s) (0.25 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.Accreditation StatementThe Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.Designation StatementThis 0.25 contact hour educational activity is provided by the Institute for Johns Hopkins Nursing. Statements will be awarded for this educational activity August 4, 2022.Policy on Privacy and ConfidentialityPlease see final activity for the policy on privacy and confidentiality that relates to this internet activity.Disclosure of Conflicts of InterestPostgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.It is the policy of the Institute for Johns Hopkins Nursing that the presenter and provider globally disclose conflicts of interest. The IJHN has established policies that will identify and resolve conflicts of interest prior to this educational activity.Faculty / Presenter Reported Financial RelationshipPaul G. Auwaerter, MD, MBA, FIDSA
Scientific Advisor: DiaSaorin, Shionogi Inc.
Ownership Equity: JNPPlanners and ManagersThe PIM planners and managers have nothing to disclose. The DKBmed planners and managers have nothing to disclose. The IJHN Nurse Planner has nothing to disclose.Media
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Non-Endorsement of Products
The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of the IJHN name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity. During the period of August 4, 2021 through August 4, 2022, participants must read the learning objectives and faculty disclosures and study the educational activity. In order to receive nursing contact hours, participants must also complete and submit an evaluation. If you wish to receive acknowledgment for completing this activity, please complete the evaluation.
Include minimum hardware, software, internet connectivity and connection speed requirements for accessing the internet-based activity.